QQ客服 官方微博 反馈留言

	Differential effects of ginkgol C17:1 on cisplatin-induced cytotoxicity: Protecting human normal L02 hepatocytes versus sensitizing human hepatoma HepG2 cells
	Li, Yueying[1]; Zhang, Xinchi[2]; Yang, Xiaoming[3]; Liu, Jun[4]; Li, Linjie[5]; Ma, Wenbin[6]; Chen, Min[7]
刊名	ONCOLOGY LETTERS
	2019
卷号	17期号:3页码:3181-3190
关键词	ginkgol C17:1 HepG2 cells L02 cells cisplatin co-treatment
ISSN号	1792-1074
DOI	http://dx.doi.org/10.3892/ol.2019.9974
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000460555900074
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5323427
专题	江苏大学
作者单位	1.[1]Jiangsu Univ, Sch Med, Dept Physiol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 2.[2]Jiangsu Univ, Sch Med, Dept Immunol, Zhenjiang 212013, Jiangsu, Peoples R China. 3.[3]Jiangsu Univ, Sch Food & Biol Engn, Dept Food Sci & Engn, Zhenjiang 212013, Jiangsu, Peoples R China. 4.[4]Jiangsu Univ, Inst Life Sci, Dept Biol, Zhenjiang 212013, Jiangsu, Peoples R China. 5.[5]Jiangsu Univ, Sch Med, Zhenjiang 212013, Jiangsu, Peoples R China. 6.[6]Jiangsu Univ, Sch Med, Zhenjiang 212013, Jiangsu, Peoples R China. 7.[7]Jiangsu Univ, Sch Med, Dept Physiol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.
推荐引用方式 GB/T 7714	Li, Yueying[1],Zhang, Xinchi[2],Yang, Xiaoming[3],et al. Differential effects of ginkgol C17:1 on cisplatin-induced cytotoxicity: Protecting human normal L02 hepatocytes versus sensitizing human hepatoma HepG2 cells[J]. ONCOLOGY LETTERS,2019,17(3):3181-3190.
APA	Li, Yueying[1].,Zhang, Xinchi[2].,Yang, Xiaoming[3].,Liu, Jun[4].,Li, Linjie[5].,...&Chen, Min[7].(2019).Differential effects of ginkgol C17:1 on cisplatin-induced cytotoxicity: Protecting human normal L02 hepatocytes versus sensitizing human hepatoma HepG2 cells.ONCOLOGY LETTERS,17(3),3181-3190.
MLA	Li, Yueying[1],et al."Differential effects of ginkgol C17:1 on cisplatin-induced cytotoxicity: Protecting human normal L02 hepatocytes versus sensitizing human hepatoma HepG2 cells".ONCOLOGY LETTERS 17.3(2019):3181-3190.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。